미반영 외신)

[경동제약]

美 리바이브, 코로나 치료제 ‘부시라민’ 임상3상 FDA에서 긍정적 의견 받아

데이터안전 및 모니터링 위원회("DSMB")와 안전성 데이터 평가 위해 미팅 예정

리바이브 주가는 21% 상승 마감

 

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

May 26, 2022

The Company received positive comments from the FDA to determine potential new clinical endpoints to support Emergency Use Authorization

 

https://revivethera.com/2022/05/revive-therapeutics-provides-update-on-phase-3-clinical-trial-for-bucillamine-in-covid-19-8/ 

https://www.cnbc.com/quotes/rvvtf?qsearchterm=rvvtf